Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current therapeutic methods in onco-hematology]

I Madelaine-Chambrin1, V Piquet-Sevrin, P Faure

  • 1Service Pharmacie, Hôpital Saint-Louis, Paris.

Annales Pharmaceutiques Francaises
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One-Day Brentuximab-Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin Lymphoma.

Hematological oncology·2024
Same author

[Virological diagnosis of anterior herpetic ocular disease on tear sample: A simple and non-invasive technique].

Journal francais d'ophtalmologie·2022
Same author

Multistep thermodesorption coupled with molecular analyses as a quick, easy and environmentally friendly way to measure PAH availability in contaminated soils.

Talanta·2021
Same author

Efficacy and tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4% hydroquinone.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Controlled imbibition in a porous medium from a soft wet material (poultice).

Soft matter·2019
Same author

Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study.

Journal of Crohn's & colitis·2019
Same journal

[Artificial Intelligence in the Pharmaceutical Industry: Governance, Quality, and Regulatory Challenges].

Annales pharmaceutiques francaises·2026
Same journal

No evidence of significant natural environmental exposure to arsenic for Napoleon I on the island of Saint Helena (1815-1821).

Annales pharmaceutiques francaises·2026
Same journal

EFFECTS OF GLP-1 RECEPTOR AGONISTS ON PERIODONTAL TISSUE: AN INTERDISCIPLINARY EVIDENCE MAPPING - SCOPING REVIEW.

Annales pharmaceutiques francaises·2026
Same journal

Regulatory non-compliance of parallel imported medicines in Kenya and implications for public health: Evidence from Nairobi County.

Annales pharmaceutiques francaises·2026
Same journal

Prostaglandin analogues in cosmetic products formulated for eyelash lengthening.

Annales pharmaceutiques francaises·2026
Same journal

Mechanistic and thermodynamic evaluation of sodium citrate-mediated hydrotropism for the biopharmaceutical optimization of BCS Class II drug atorvastatin calcium.

Annales pharmaceutiques francaises·2026
See all related articles

New anticancer drugs with novel mechanisms are emerging, including taxanes for breast and ovarian cancers, DNA-Topoisomerase I inhibitors for solid tumors, and adenosine analogs for leukemia. All-trans retinoic acid offers a new approach for acute promyelocytic leukemia.

Area of Science:

  • Oncology
  • Pharmacology
  • Hematology

Background:

  • Advancements in cancer treatment are driven by the development of novel anticancer drugs.
  • Newer agents offer improved efficacy and target specific molecular pathways.

Purpose of the Study:

  • To review recent advancements in anticancer drug development.
  • To highlight novel therapeutic agents and their mechanisms of action.

Main Methods:

  • Literature review of recently approved and investigational anticancer drugs.
  • Summary of clinical efficacy and mechanisms of action for key drug classes.

Main Results:

  • Taxanes (Taxol, Taxotere) show efficacy in advanced ovarian and breast cancers.

Related Experiment Videos

  • DNA-Topoisomerase I inhibitors expand therapeutic options for solid tumors.
  • Adenosine analogs (fludarabine, cladribine) are key in hematologic malignancies.
  • All-trans retinoic acid offers a novel differentiation therapy for acute promyelocytic leukemia.

    • Conclusions:

    • A new era of cancer treatment is emerging with diverse therapeutic strategies.
    • Ongoing research continues to yield promising new anticancer agents.
    • Targeted therapies and differentiation agents represent significant progress in oncology.